Lack of proper diet and use of different medications in heart failure contributes to electrolyte imbalance. Due to absence of routine measurement, their abnormalities are not recognized. This study is an attempt to portrait a picture of serum levels of electrolytes in heart failure patients Materials and Methods: 102 heart failure patients were enrolled in this study over 6 months period. Serum levels of magnesium, calcium, phosphorus, sodium and albumin were measured. SPSS ver. 20.0 was used to analyze the data. Analysis of Variance was used to find mean differences and Pearson's correlation was used to establish the correlation. Results: Majority of patient fell under New York Heart Association (NYHA) class II and had isolated systolic heart failure. Mean serum values of sodium and magnesium were below the reference range. Mean values of serum sodium, magnesium and corrected calcium was less in patients receiving diuretics and digitalis. Likewise, serum phosphorus was more with diuretics and digitalis use. Also, serum sodium was less in Acetylcholine Eseterose (ACE) inhibitors use. Isolated diastolic heart failure patients had least serum calcium values. Although, serum sodium and magnesium value in heart failure patients was positively correlated, was not statistically significant. Conclusion: This study showed that low serum sodium and magnesium values are frequently associated in heart failure. Disturbances in other serum electrolytes could also be other cause of complications in heart failure which are not under routine investigation. Identification and correction of these disturbances could have significant impact. However, further studies are required to reinforce this idea.
INTRODUCTION
Frequent electrolyte abnormalities encountered in chronic congestive heart failure (CHF) are hypomagnesemia, hypokalemia & hyponatremia. Among these, magnesium and potassium may contribute to the high mortality and sudden death. 1 Deficiency of these cations occurs as a result of reduced intake or increased loses. Hypomagnesemia is often associated with imbalance of electrolytes like sodium, potassium and calcium. As magnesium serves as a cofactor in several important transporters, deficiency can lead to increased intracellular sodium and calcium concentrations, both of which can lead to increased peripheral resistance and vasospasm. [2] [3] Altered expression and activity of calcium-related proteins are associated with cardiac dysfunction. [4] [5] Hyperphosphatemia may influence Cardio Vascular Disease (CVD) risk through vascular calcification, myocardial fibrosis, and development of left ventricular hypertrophy. [6] [7] [8] The association between serum electrolytes and heart failure patients has not been established so far, in this tertiary center as per the knowledge of the researcher. Thus this study aims to assess the electrolyte status, determine their association in patient with Heart Failure (HF) and hence advocate the need of regular electrolyte monitoring during course of management.
MATERIAL AND METHOD
A total of 102 heart failure patients admitted under department of cardiology, Manmohan Cardiothoracic Vascular and Transplant Centre (MCVTC) were enrolled in this study over 6 months period between March and August 2015. Diagnosis of heart failure was based on the findings of electrocardiogram and echocardiography along with other laboratory parameters like brain natriuretic peptide. Heart failure was classified with New York Heart Association (NYHA) classification and based on left ventricular ejection fraction (LVEF). [9] [10] All patients who presented to the MCVTC between March and August 2015, with HF, who provide written consent for the study were included. Patients with any known malignant disease, acute or chronic inflammatory or infectious disease like sepsis, arthritis or connective tissue disorder, chronic liver disease and renal failure and thyroid disorders were excluded from study. The research protocol was approved by Institutional Review Board (IRB), Institute of Medicine, Nepal. In this study, non-probability (convenience) sampling was done and a total of 102 patients were included. Blood samples were collected for various tests which were done without financial burden to the patient. During this study, there was no risk for human participants and no interventions were carried out. A performa sheet was filled at the ward, ICU and CCU with a detailed history of the patient including the chief complaint, past and present medical history, drug history and vitals. Then 5ml of blood was drawn from the patients under aseptic condition. The blood was taken to the laboratory within 2 hours and centrifuged at 4000 rpm for 5 minutes, aliquotted and stored at -200 C until analysis. Serum levels of magnesium (total), calcium, phosphorus, and albumin were measured in all the patients using fully automated chemistry analyzer, BT 3000, Italy. Serum calcium was adjusted for serum albumin by using following equation: Corrected calcium = measured total calcium (mg/dl) + 0.8 [4 -serum albumin (g/dl). A serum level of sodium was determined by ion selective electrode method using fully automated electrode analyser EX-D S/N JE A1 5060050, Japan. Statistical analysis of the data was done using SPSS ver. 20.0. Analyses included standard descriptive variable summaries, measures of distribution with frequency tables and quantitative variables expressed in terms of mean ± SD. Analysis of Variance was used to find mean differences and Pearson's correlation was used to establish the correlation between study variables.
RESULTS
Of the 102 patients, 65 (63.7%) were males and 37 (36.3%) were females. Mean age of presentation was 58.26 ± 16 yrs and ranged from 10-90 years. Majority were smokers, male were dominant in alcohol consumption and majority of hypertensive were under treatment. In this study we found that smoking, advancing age, diabetes mellitus and hypertension were associated with heart failure occurrence. A greater proportion of the patients received diuretics (84.3%), followed by ACE inhibitors (52.9%), and digitalis (31.4%) ( Table I) . Majority of the study population (44.1%) fell under NYHA class II. Moreover, study findings also revealed that approximately 66% of the selected patients had isolated systolic heart failure. Mean serum values of sodium (133 6) and magnesium (1.36 0.61) were below the reference range as shown in Table II . Mean values of serum sodium, magnesium and corrected calcium were found to be lower among patients receiving diuretics and digitalis than compared to the non-prescribed ones as shown in Table III & IV. Likewise, mean value of serum phosphorus was higher among those on diuretics and digitalis than compared to those who did not receive any of them. In the similar fashion, mean value of serum sodium was lower among those prescribed ACE inhibitors as compared to those who did not receive AEC inhibitors; but other study variables had opposite effect (Table V) . Although, serum sodium and magnesium value in heart failure patients was positively correlated, was not statistically significant (Pearson's r = 0.1, p = 0.32) ( Fig  I) .
Fig I: scatter plot showing relation between serum sodium and magnesium
Isolated diastolic heart failure patients had least serum calcium values (Table VI) . 
DISCUSSION
Heart failure has been singled out as an epidemic and is a staggering clinical and public health problem, associated with significant mortality, morbidity, and healthcare expenditures, particularly among those aged 65 and older. 11 Despite progress in reducing HF-related mortality, hospitalizations for HF remain very frequent and rates of readmissions continuing to rise. 11 Using standardized criteria, the incidence of HF in an earlier study from Framingham was between 1.4 and 2.3 per 1000/year among persons 29 to 79 years old. 12 In support of this finding, our study also depicted that 92. and potentially dangerous complication in subjects with congestive heart failure. This may be due either to the pathophysiological alterations present in the heart failure state leading to neurohumoral activation, or to the adverse events of therapy with diuretics, cardiac glycosides, and ACE inhibitors. 13 Subjects with heart failure may show hyponatremia, magnesium, and potassium deficiencies; the latter two play a pivotal role in the development of cardiac arrhythmias. The early identification of these alterations and the knowledge of the pathophysiological mechanisms are very useful for the management of this patients. 13 Hyponatremia is considered an important risk factor for poor outcome, magnesium has only rarely been considered as independent risk factor for poor outcome in CHF patients. However, magnesium is essential for normal functioning of the cardiovascular system and hypomagnesemia is a common condition in hospitalized patients. 14 In this study the mean values of serum sodium (133 ± 6.0) and serum magnesium (1.36 ± 0.61) were below the reference range. There is also confirmation that the effective correction of magnesium disturbances is favorable in CHFsubjects. 15 Else, serum magnesium ≤2mEq/L was associated with increased cardiovascular mortality in patients with chronic heart failure. 16 In the setting of CHF, magnesium depletion stems from reduced dietary intake, altered distribution of the ion, and renal losses. It should also be considered that edematous states, involving the intestinal mucosa, might interfere with the absorption of microelements, such as magnesium. Respiratory alkalosis may produce a decrease in serum magnesium due to a shift of magnesium inside the intracellular compartment. 17 Diuretics (loop-acting diuretics in particular) produce most of renal magnesium loss, especially in the volume expanded setting of CHF and in associated hyperaldosteronism. 17 In our case also mean values in case of diuretic use (1.35± 0.63) was lower than the values among non prescribed patients (1.41 ± 0.48) but the mean difference was not statistically significant, although values were below the reference range. Digoxin directly limits the renal tubular reabsorption of magnesium, therefore increasing magnesium excretion; a low magnesium concentration increases the action of cardiac glycoside. 13 Our study results are in accordance with this finding which also showed that the mean value was lower among the digoxin users (1.23± 0.64) as compared to the non-users (1.42 ± 0.59) but the difference was not statistically significant, although values were below the reference range. Angiotensin converting enzyme inhibitors should have all the advantages of conventional vasodilators in the treatment of cardiac failure together with several substantial additional benefits. Angiotensin II is an important stimulus to aldosterone secretion, 18 and lowering plasma angiotensin II by angiotensin converting enzyme inhibition should reduce aldosterone secretion and thus facilitate diuresis while also correcting any deficiency of potassium and magnesium associated with diuretic therapy and aldosterone excess. 19 In this study, those patients receiving ACE inhibitors had higher mean serum value (1.38± 0.53) than those not receiving them (1.34 ± 0.69), but the difference was not statistically significant.
Mild-to moderate hyponatremia is generally present in 10 % of HF subjects. 20 In this study, mean value of sodium (133 ± 6.0), which is indication of hyponatremia.
In the OPTIME-CHF 22 In this study mean value in diuretics prescribed patients (133.06 ± 6.41) was less than non prescribed patients (134.0 ± 3.35), although the difference was not statistically significant.
In every day practice, HF patients usually receive ACE Inhibitors(ACEIs), β-blockers, and aldosterone antagonists without the measurement of baseline calcium levels. The effect of maximizing HF therapy on serum calci um levels remains unknown and the published guidelines do not recommend any specific ther apy in patients with abnormal levels observed during escalation of HF therapy. An association between abnormal serum calcium levels during therapy maximization and clinical outcome has not been investigated so far. 23 In this study, mean serum value of calcium is within reference normal range for three different class of heart failure. But the mean value of diastolic heart failure (7.99 ± 2.52) differed significantly with the mean values of systolic (9.28 ± 1.02) and combined form (9.56 ±1.09). Left ventricular (LV) diastolic dysfunction in patients with chronic kidney disease (CKD) is of a complex nature and is mostly associated. 24 In CKD patients, depending on the stage of the disease, the biochemical disturbances are dominated by a decreased level of serum Ca, especially its ionized fraction (Ca 2+ ) in plasma. In this study renal failure patients were excluded, so its value might been fall in normal reference range, but mean values of diastolic heart failure was relatively less than that of other two forms.
A study by Rozentryt P et al. analyzed predictors of hypo and hyper phosphatemia and relation to prognosis. Hypophosphatemia was associated with better response to therapy, was more prevalent in milder HF, and the association was independent of age, sex, BMI, etiology of HF, kidney function and the use of diuretics. Patients with hyperphosphatemia on top of optimal therapy responded worse to treatment. 23 The prognostic impact of serum phosphorus abnormalities remains to be established. In this study mean value of serum phosphorus was within the normal range and renal disease was excluded. CONCLUSION CHF subjects develop electrolyte abnormalities due to several pathophysiological mechanisms. Their incidence is often correlated with the severity of cardiac dysfunction; furthermore, these imbalances are associated with a poor prognosis. Many of these metabolic derangements are drug-induced; therefore, these subjects need close monitoring. When treating CHF, one must consider how to prevent and to correct electrolyte imbalances and to prolong patient better survival. Disturbances in other electrolytes could also be other cause of complications in heart failure which are not under routine investigation. Identification and correction of these disturbances could have significant impact in patient outcome. However,
